Politics - STAT

Politics

Top U.S. health officials say they were never told to slow down Covid-19 testing, contradicting Trump

By Lev Facher

Politics

The new Janet: The FDA turns to a quiet problem-solver who brings expertise — and a little controversy

By Nicholas Florko

Politics

Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs

By Ed Silverman

Politics

As Covid-19 devastates communities of color, the government’s minority health experts are conspicuously quiet

By Lev Facher

Politics

Trump says Covid-19 is ‘dying out.’ Experts fear his dismissiveness could prolong the crisis

By Lev Facher and Andrew Joseph

Politics

Trump administration seeks to encourage ‘value-based’ drug pricing deals with new proposal

By Nicholas Florko

Politics

Trump administration pledges future Covid-19 vaccines will be free for ‘vulnerable’ Americans

By Lev Facher

Politics

Supreme Court deals a series of blows to generic drug companies

By Nicholas Florko

Politics

What does the FDA’s hydroxychloroquine decision mean for Covid-19 patients or politicians? And 4 other burning questions

By Nicholas Florko

Hydroxychloroquine at Rock Canyon Pharmacy

Politics

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

By Lev Facher

Politics

PhRMA’s top communicator, a fierce defender of the industry, leaves for ExxonMobil

By Nicholas Florko

Politics

The coronavirus pandemic is reigniting a fierce debate over compounded drugs

By Nicholas Florko

Politics

Lawmakers, government watchdog blast FDA for poor oversight of U.S. drug supply chain

By Nicholas Florko

Politics

Debate over hydroxychloroquine spills over from the White House to congressional campaigns

By Lev Facher

Politics

Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19 pandemic

By Andrew Joseph and Helen Branswell

Politics

Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare

By Nicholas Florko

Politics

Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.

By Nicholas Florko

Politics

FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on Covid-19 vaccine project

By Nicholas Florko

Politics

Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals

By Nicholas Florko

Politics

9 ways Covid-19 may forever upend the U.S. health care industry

By Lev Facher

Politics

In combative remarks, Azar tells WHO that its Covid-19 response ‘cost many lives’

By Lev Facher

Politics

Trump administration outlines audacious plan to deliver ‘hundreds of millions’ of Covid-19 vaccine doses by end of 2020

By Lev Facher

Politics

Rick Bright is facing attacks from Republicans across Washington, but his opponents can’t seem to land a punch

By Nicholas Florko

Politics

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

By Nicholas Florko

Exclusive

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?

By Nicholas Florko and Matthew Herper

Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies

Trouble in paradise: The Senate’s bipartisan accord on drug prices is broken, says Grassley

As Covid-19 cases surge, Pence touts progress made from earlier peaks

Ousted federal vaccine expert alleges health secretary has continued to retaliate

Top U.S. health officials say they were never told to slow down Covid-19 testing, contradicting Trump

The new Janet: The FDA turns to a quiet problem-solver who brings expertise — and a little controversy

Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs

As Covid-19 devastates communities of color, the government’s minority health experts are conspicuously quiet

Trump says Covid-19 is ‘dying out.’ Experts fear his dismissiveness could prolong the crisis

Trump administration seeks to encourage ‘value-based’ drug pricing deals with new proposal

Trump administration pledges future Covid-19 vaccines will be free for ‘vulnerable’ Americans

Supreme Court deals a series of blows to generic drug companies

What does the FDA’s hydroxychloroquine decision mean for Covid-19 patients or politicians? And 4 other burning questions

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

PhRMA’s top communicator, a fierce defender of the industry, leaves for ExxonMobil

The coronavirus pandemic is reigniting a fierce debate over compounded drugs

Lawmakers, government watchdog blast FDA for poor oversight of U.S. drug supply chain

Debate over hydroxychloroquine spills over from the White House to congressional campaigns

Trump: U.S. will terminate relationship with the World Health Organization in wake of Covid-19 pandemic

Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare

Pharma panics as Washington pushes to bring drug manufacturing back to the U.S.

FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on Covid-19 vaccine project

Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals

9 ways Covid-19 may forever upend the U.S. health care industry

In combative remarks, Azar tells WHO that its Covid-19 response ‘cost many lives’

Trump administration outlines audacious plan to deliver ‘hundreds of millions’ of Covid-19 vaccine doses by end of 2020

Rick Bright is facing attacks from Republicans across Washington, but his opponents can’t seem to land a punch

Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response

Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?